Recently, researchers have reported that FSTL1 up-regulates the BMP4-Smad signaling in lung adenocarcinoma (11), while in glioblastoma, FSTL1 down-regulates the same signaling (21). The gene discussed is FSTL1; the disease is glioblastoma.